Finshots Daily cover image

The downfall of 23andMe?

Finshots Daily

The Potential Downfall of 23andMe: False Positives, Data Security, and Drug-Making Ambitions

4min Snip

00:00
Play full episode
This chapter explores the potential downfall of 23andMe, discussing the risks of false positives in genetic testing, concerns over data security and privacy, and the challenges of becoming a drug maker. It also highlights investors' reluctance to invest further in the company and the uncertainty surrounding its future.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode